Finnish Health Tech Company alveos Develops Acoustic Sensing Method to Monitor Breathing Through Chest Vibrations

Introduction to Alveos' Acoustic Sensing Method

Alveos, a health technology company based in New York and Helsinki, has developed a novel mechano-acoustic sensing method for noninvasive respiratory monitoring. This approach measures breathing through the detection of chest vibrations and pressure changes, offering an alternative to traditional optical or airflow-based techniques.

The system employs high-sensitivity acoustic sensors that are placed in contact with the body to capture vibration patterns during respiration. These sensors are designed to clip onto clothing, maintaining stable skin contact via a magnetic mechanism, thus eliminating the need for adhesives.

Data captured by the sensors is processed on-device to assess breathing rate, rhythm, and depth, without the use of cameras, airflow masks, or optical measurements. This design aims to provide continuous monitoring in everyday scenarios.

Alveos integrates machine learning models trained on diverse respiratory data to interpret breathing dynamics over time. This processing occurs locally on the device, ensuring data minimization and privacy. The system offers feedback through an AI breathing coach, designed to guide users based on their specific goals.

While business operations are conducted in New York, research and development activities take place in Helsinki. Alveos is supported by early-stage venture capital from Antler and has completed pre-seed funding with a valuation of approximately €5 million.

Although the current focus is on the sensing method, Alveos plans to launch the product in the market by the fourth quarter of 2026. Pre-orders are available through a Kickstarter campaign.

Based on reporting by TechBullion.